Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ritchie

Showing results (211-220 of 265) with videos related to

Pageof 27
Sort By:
British Journal of Pharmacology|September 2, 2023
The small-molecule formyl peptide receptor biased agonist, compound 17b, is a vasodilator and anti-inflammatory in mouse precision-cut lung slicesWilliam R Studley, Emma Lamanna, Katherine A Martin, et al.
Nitric Oxide : Biology and Chemistry|May 10, 2011
The endogenous NOS inhibitor asymmetric dimethylarginine (ADMA) predicts LV mass independent of afterloadA L Sverdlov, D T M Ngo, A K Nightingale, et al.
Frontiers in Physiology|March 11, 2020
Defining the Progression of Diabetic Cardiomyopathy in a Mouse Model of Type 1 DiabetesMiles J De Blasio, Nguyen Huynh, Minh Deo, et al.
Clinical Science (London, England : 1979)|May 11, 2017
Phosphoinositide 3-kinase (p110α) gene delivery limits diabetes-induced cardiac NADPH oxidase and cardiomyopathy in a mouse model with established diastolic dysfunctionDarnel Prakoso, Miles J De Blasio, Chengxue Qin, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 6, 2024
The pro-resolving mediator, annexin A1 regulates blood pressure, and age-associated changes in cardiovascular function and remodelingJaideep Singh, Kristy L Jackson, Feng Shii Tang, et al.
British Journal of Pharmacology|October 20, 2010
Myocardial oxidative stress contributes to transgenic β₂-adrenoceptor activation-induced cardiomyopathy and heart failureQ Xu, A Dalic, L Fang, et al.
British Journal of Pharmacology|November 15, 2019
Annexin-A1 deficiency exacerbates pathological remodelling of the mesenteric vasculature in insulin-resistant, but not insulin-deficient, miceMaria Jelinic, Nicola Kahlberg, Chen Huei Leo, et al.
Hypertension (Dallas, Tex. : 1979)|March 9, 2011
Determination of the exact molecular requirements for type 1 angiotensin receptor epidermal growth factor receptor transactivation and cardiomyocyte hypertrophyNicola J Smith, Hsiu-Wen Chan, Hongwei Qian, et al.
Frontiers in Pharmacology|October 25, 2021
Bone Morphogenetic Protein 7 Gene Delivery Improves Cardiac Structure and Function in a Murine Model of Diabetic CardiomyopathyMitchel Tate, Nimna Perera, Darnel Prakoso, et al.
British Journal of Pharmacology|April 2, 2022
Cardioprotective actions of nitroxyl donor Angeli's salt are preserved in the diabetic heart and vasculature in the face of nitric oxide resistanceAnida Velagic, Jasmin Chendi Li, Cheng Xue Qin, et al.
Pageof 27

Showing results (211-220 of 265) with videos related to

Sort By:
Pageof 27
British Journal of Pharmacology|September 2, 2023
The small-molecule formyl peptide receptor biased agonist, compound 17b, is a vasodilator and anti-inflammatory in mouse precision-cut lung slicesWilliam R Studley, Emma Lamanna, Katherine A Martin, et al.
Nitric Oxide : Biology and Chemistry|May 10, 2011
The endogenous NOS inhibitor asymmetric dimethylarginine (ADMA) predicts LV mass independent of afterloadA L Sverdlov, D T M Ngo, A K Nightingale, et al.
Frontiers in Physiology|March 11, 2020
Defining the Progression of Diabetic Cardiomyopathy in a Mouse Model of Type 1 DiabetesMiles J De Blasio, Nguyen Huynh, Minh Deo, et al.
Clinical Science (London, England : 1979)|May 11, 2017
Phosphoinositide 3-kinase (p110α) gene delivery limits diabetes-induced cardiac NADPH oxidase and cardiomyopathy in a mouse model with established diastolic dysfunctionDarnel Prakoso, Miles J De Blasio, Chengxue Qin, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 6, 2024
The pro-resolving mediator, annexin A1 regulates blood pressure, and age-associated changes in cardiovascular function and remodelingJaideep Singh, Kristy L Jackson, Feng Shii Tang, et al.
British Journal of Pharmacology|October 20, 2010
Myocardial oxidative stress contributes to transgenic β₂-adrenoceptor activation-induced cardiomyopathy and heart failureQ Xu, A Dalic, L Fang, et al.
British Journal of Pharmacology|November 15, 2019
Annexin-A1 deficiency exacerbates pathological remodelling of the mesenteric vasculature in insulin-resistant, but not insulin-deficient, miceMaria Jelinic, Nicola Kahlberg, Chen Huei Leo, et al.
Hypertension (Dallas, Tex. : 1979)|March 9, 2011
Determination of the exact molecular requirements for type 1 angiotensin receptor epidermal growth factor receptor transactivation and cardiomyocyte hypertrophyNicola J Smith, Hsiu-Wen Chan, Hongwei Qian, et al.
Frontiers in Pharmacology|October 25, 2021
Bone Morphogenetic Protein 7 Gene Delivery Improves Cardiac Structure and Function in a Murine Model of Diabetic CardiomyopathyMitchel Tate, Nimna Perera, Darnel Prakoso, et al.
British Journal of Pharmacology|April 2, 2022
Cardioprotective actions of nitroxyl donor Angeli's salt are preserved in the diabetic heart and vasculature in the face of nitric oxide resistanceAnida Velagic, Jasmin Chendi Li, Cheng Xue Qin, et al.
Pageof 27